Investor relations
Nordhealth is a company listed on Euronext Growth as NORDH
Investor presentations
A brief overview of the company and recent history.
- Watch Q2/2023 investor presentation recordingAugust 22, 2023
- Download Q2/2023 presentationAugust 22, 2023
- Watch Q1/2023 investor presentation recordingMay 16, 2023
- Download Q1/2023 presentationMay 16, 2023
- Watch Q4/2022 investor presentation recordingMarch 7, 2022
- Download Q4/2022 presentationMarch 7, 2023
- Watch Q3/2022 investor presentation recordingNovember 25, 2022
- Download Q3/2022 presentationNovember 25, 2022
- Watch Q2/2022 investor presentation recordingAugust 16, 2022
- Download Q2/2022 presentationAugust 16, 2022
- Watch Q1/2022 investor presentation recordingMay 20, 2022
- Download Q1/2022 presentationMay 20, 2022
- Watch Q4/2021 investor presentation recordingMarch 8, 2022
- Download Q4/2021 presentationMarch 8, 2021
- Watch EasyPractice acquisition investor presentationFebruary 2, 2022
- Watch Q3/2021 investor presentation recordingNovember 30, 2021
- Download Q3/2021 presentationNovember 30, 2021
- Watch H1/2021 investor presentation recordingSeptember 30, 2021
- Download H1/2021 presentationSeptember 30, 2021
- Download Nordhealth introductionJune 3, 2021
Financial reports
- Download H1/2023 reportAugust 22, 2023
- Annual Financial Statements 2022April 14, 2023
- Download H2/2022 reportMarch 7, 2023
- Download H1/2022 reportAugust 16, 2022
- Annual Financial Statements 2021April 29, 2021
- Download Q4/2021 reportMarch 8, 2021
- Download Q3/2021 reportNovember 30, 2021
- Download H1/2021 reportSeptember 30, 2021
Admission document
The attached information document has been prepared by Nordhealth solely for use in connection with the admission to trading of the Company’s class A shares on Euronext Growth Oslo, commencing on 3 June 2021.
Stock exchange releases
Get the latest stock exchange releases directly from our news platform.
- Nordhealth AS: Q2 and first half 2023 interim financial reportAugust 22, 2023
- Nordhealth AS - Invitation to Q2 2023 presentationAugust 15, 2023
- Nordhealth AS completes share buyback programJune 30, 2023
- Mandatory notification of tradeJune 28, 2023
- Transactions carried out under the share buy-back programJune 22, 2023
- Mandatory notification of tradeJune 16, 2023
- Transactions carried out under the share buy-back programJune 13, 2023
- Nordhealth AS initiates share buyback programJune 5, 2023
- Mandatory notification of tradeMay 26, 2023
- Mandatory notification of tradeMay 25, 2023